Cargando…

A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study

INTRODUCTION: Basal insulin should be injected at the same time each day, but people with diabetes sometimes mistime their injections. It is not known whether irregular daily dose timing affects diabetes-related factors. We report here our evaluation of the effects of deviations from a regular dosin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishimura, Akiko, Harashima, Shin-ichi, Fukushige, Haruna, Wang, Yu, Liu, Yanyan, Hosoda, Kiminori, Inagaki, Nobuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380500/ https://www.ncbi.nlm.nih.gov/pubmed/28236272 http://dx.doi.org/10.1007/s13300-017-0238-7

Ejemplares similares

Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study
por: Nishimura, Akiko, et al.
Publicado: (2018)

Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study
por: Nishimura, Akiko, et al.
Publicado: (2019)

Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion
por: Wang, Yu, et al.
Publicado: (2017)

The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism
por: Tomita, Tsutomu, et al.
Publicado: (2014)

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Long‐term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2017)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
por: Roussel, Ronan, et al.
Publicado: (2020)

Predictors for Mild and Severe Hypoglycemia in Insulin-Treated Japanese Diabetic Patients
por: Sonoda, Nao, et al.
Publicado: (2015)

Sorting nexin 19 regulates the number of dense core vesicles in pancreatic β‐cells
por: Harashima, Shin‐ichi, et al.
Publicado: (2011)

Weight-Based, Insulin Dose–Related Hypoglycemia in Hospitalized Patients With Diabetes
por: Rubin, Daniel J., et al.
Publicado: (2011)

Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
por: Fadini, Gian Paolo, et al.
Publicado: (2019)

Role of clock genes in insulin secretion
por: Harada, Norio, et al.
Publicado: (2016)

Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study
por: Akagi, Yuuki, et al.
Publicado: (2020)

Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
por: Mitsuishi, Sumie, et al.
Publicado: (2015)

Efficacy and safety of canagliflozin as add‐on therapy to a glucagon‐like peptide‐1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52‐week, open‐label, phase IV study
por: Harashima, Shin‐ichi, et al.
Publicado: (2018)

Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8
por: Harris, Cynthia, et al.
Publicado: (2017)

Cell‐autonomous defects contribute to insulin resistance in skeletal muscle
por: Fujita, Yoshihito, et al.
Publicado: (2021)

Cross‐cultural comparison of predictors for self‐care behaviors in patients with type 2 diabetes
por: Ikeda, Kaori, et al.
Publicado: (2018)

Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
por: Nagao, Mototsugu, et al.
Publicado: (2023)

Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia
por: Johansen, Odd Erik, et al.
Publicado: (2009)

Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study
por: Bosnyak, Zsolt, et al.
Publicado: (2019)

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing
por: Nishimura, Erica, et al.
Publicado: (2021)

Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia
por: McNicholas, Bairbre A., et al.
Publicado: (2017)

Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk
por: Choudhary, Pratik, et al.
Publicado: (2011)

Social Orientation and Diabetes-Related Distress in Japanese and American Patients with Type 2 Diabetes
por: Ikeda, Kaori, et al.
Publicado: (2014)

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: A report of five cases
por: Yoshiji, Satoshi, et al.
Publicado: (2017)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
por: Nasrallah, Sami N., et al.
Publicado: (2012)

Ubc13 haploinsufficiency protects against age-related insulin resistance and high-fat diet-induced obesity
por: Joo, Erina, et al.
Publicado: (2016)

Importance of Insulin Immunoassays in the Diagnosis of Factitious Hypoglycemia
por: Nalbantoğlu Elmas, Özlem, et al.
Publicado: (2014)

The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017)

Paliperidone Induced Hypoglycemia by Increasing Insulin Secretion
por: Omi, Tsubasa, et al.
Publicado: (2016)

Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization
por: Dalal, Mehul R., et al.
Publicado: (2017)

Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary
por: Anderson, John, et al.
Publicado: (2020)

Carbohydrate intake is associated with time spent in the euglycemic range in patients with type 1 diabetes
por: Ayano-Takahara, Shiho, et al.
Publicado: (2015)

Hypoglycemia Unawareness in Insulinoma Revealed with Flash Glucose Monitoring Systems
por: Sugawa, Taku, et al.
Publicado: (2018)

Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes
por: Groener, Jan Benedikt, et al.
Publicado: (2019)

Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
por: Boucher-Berry, Claudia, et al.
Publicado: (2016)

Effect of Naloxon on Counter Insulin Hormone Secretion in Insulin-Induced Hypoglycemia
por: Ju, Yeong Shil, et al.
Publicado: (1987)

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
por: Su, Chih-Ting, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2fmcmkdcj5ie3os8vugvd7g4kj